Anthony R. Harris - Concepedia

Author

Anthony R. Harris

Pfizer (United States)ORCID

Also Known As

A Harris, A R Harris, A.R. Harris, ANTHONY R. HARRIS, Anthony Harris, Anthony R. Harris, Harris, Anthony, Zhang, Jinzhi

Publications

1.8K

Citations

H-Index

103

Concepts

All Affiliations

Pfizer (United States)DuPont (United States)University of Massachusetts Amherst Bristol-Myers Squibb (United States)Harvard University

About

Anthony R. Harris is an author at Pfizer (United States) specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	5	5	110
2	Education	4	4	120
3	Law	3	3	430
4	Business	1	1	28
5	Health Sciences	1	1	18

Anthony R. Harris

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Sex and Theories of Deviance: Toward a Functional Theory of Deviant Type-Scripts Anthony R. Harris American Sociological Review LawCriminal LawSex VariableSocial SciencesFunctional Theory	1977	236
Murder and Medicine Anthony R. Harris, Stephen H. Thomas, Gene A. Fisher, Homicide Studies Criminal CodeViolence AssessmentDangerous WeaponsLawCriminal Law	2002	166
Labeling a Hydrazino Nicotinamide-Modified Cyclic IIb/IIIa Receptor Antagonist with <sup>99m</sup>Tc Using Aminocarboxylates as Coligands Shuang Liu, David S. Edwards, Richard Looby, Bioconjugate Chemistry PharmacotherapyChemical BiologyPharmaceutical ChemistryReaction TimeMolecular Pharmacology	1996	118
New and Versatile Ternary Ligand System for Technetium Radiopharmaceuticals: Water Soluble Phosphines and Tricine as Coligands in Labeling a Hydrazinonicotinamide-Modified Cyclic Glycoprotein IIb/IIIa Receptor Antagonist with <sup>99m</sup>Tc David S. Edwards, Shuang Liu, John Barrett, Bioconjugate Chemistry	1997	109
Discovery of the Potent and Selective M1 PAM-Agonist<i>N</i>-[(3<i>R</i>,4<i>S</i>)-3-Hydroxytetrahydro-2<i>H</i>-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects Jennifer E. Davoren, Che‐Wah Lee, Michelle R. Garnsey, Journal of Medicinal Chemistry	2016	83
Discovery of Trifluoromethyl Glycol Carbamates as Potent and Selective Covalent Monoacylglycerol Lipase (MAGL) Inhibitors for Treatment of Neuroinflammation Laura A. McAllister, Christopher R. Butler, Scot Mente, Journal of Medicinal Chemistry Chemical BiologyMedicinal ChemistryPharmaceutical ScienceCompound 15Biochemistry	2018	78
<sup>99m</sup>Tc-Labeling of a Hydrazinonicotinamide-Conjugated Vitronectin Receptor Antagonist Useful for Imaging Tumors Shuang Liu, David S. Edwards, Marisa C. Ziegler, Bioconjugate Chemistry Tc LabelingPharmaceutical ScienceImaging AgentSame Technetium ComplexPharmacotherapy	2001	76
Azetidine and Piperidine Carbamates as Efficient, Covalent Inhibitors of Monoacylglycerol Lipase Christopher R. Butler, Elizabeth Beck, Anthony R. Harris, Journal of Medicinal Chemistry Covalent InhibitorsBioorganic ChemistrySelective Magl InhibitorPharmacotherapyPiperidine Carbamates	2017	75
A Novel Ternary Ligand System for <sup>99m</sup>Tc-Labeling of Hydrazino Nicotinamide-Modified Biologically Active Molecules Using Imine-N-Containing Heterocycles as Coligands Shuang Liu, David S. Edwards, Anthony R. Harris Bioconjugate Chemistry	1998	66
Design and Synthesis of γ- and δ-Lactam M<sub>1</sub> Positive Allosteric Modulators (PAMs): Convulsion and Cholinergic Toxicity of an M<sub>1</sub>-Selective PAM with Weak Agonist Activity Jennifer E. Davoren, Michelle R. Garnsey, Betty Pettersen, Journal of Medicinal Chemistry	2017	58

Page 1